The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2) - A putative L-shaped binding conformation utilizing the top channel region

被引:106
作者
Rowlinson, SW
Crews, BC
Lanzo, CA
Marnett, LJ
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem,Vanderbilt Canc Ctr,Ctr Mol Toxicol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.274.33.23305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chemical mandates for arachidonic acid conversion to prostaglandin G(2) within the cyclooxygenase (COX) active site predict that the substrate will orient in a kinked or L-shaped conformation. Molecular modeling of arachidonic acid in sheep COX-1 confirms that this L-shaped conformation is possible, with the carboxylate moiety binding to Arg-120 and the omega-end positioned above Ser-530 in a region termed the top channel. Mutations of Gly-533 to valine or leucine in the top channel of mCOX-2 abolished the conversion of arachidonic acid to prostaglandin G(2), presumably because of a steric clash between the omega-end of the substrate and the introduced side chains. A smaller G533A mutant retained partial COX activity. The loss of COX activity with these mutants was not the result of reduced peroxidase activity, because the activity of all mutants was equivalent to the wild-type enzyme and the addition of exogenous peroxide did not restore full COX activity to any of the mutants. However, the Gly-533 mutants were able to oxidize the carbon 18 fatty acid substrates linolenic acid and stearidonic acid, which contain an allylic carbon at the omega-5 position. In contrast, linoleic acid, which is like arachidonic acid in that its most omega-proximal allylic carbon is at the omega-8 position, was not oxidized by the Gly-533 mutants, Finally, the ability of Gly-533 mutants to efficiently process omega-5 allylic substrates suggests that the top channel does not serve as a product exit route indicating that oxygenated substrate diffuses from the cyclooxygenase active site in a membrane proximal direction.
引用
收藏
页码:23305 / 23310
页数:6
相关论文
共 27 条
[1]   Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1 [J].
Bhattacharyya, DK ;
Lecomte, M ;
Rieke, CJ ;
Garavito, RM ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2179-2184
[2]   HIGHER OXIDATION-STATES OF PROSTAGLANDIN-H SYNTHASE - RAPID ELECTRONIC SPECTROSCOPY DETECTED 2 SPECTRAL INTERMEDIATES DURING THE PEROXIDASE REACTION WITH PROSTAGLANDIN-G2 [J].
DIETZ, R ;
NASTAINCZYK, W ;
RUF, HH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :321-328
[3]   Cyclooxygenase in biology and disease [J].
Dubois, RN ;
Abramson, SB ;
Crofford, L ;
Gupta, RA ;
Simon, LS ;
Van De Putte, LBA ;
Lipsky, PE .
FASEB JOURNAL, 1998, 12 (12) :1063-1073
[4]   A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors [J].
Gierse, JK ;
McDonald, JJ ;
Hauser, SD ;
Rangwala, SH ;
Koboldt, CM ;
Seibert, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15810-15814
[5]   Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover - Detection of the radical derivative of tyrosine 385 [J].
Goodwin, DC ;
Gunther, MR ;
Hsi, LC ;
Crews, BC ;
Eling, TE ;
Mason, RP ;
Marnett, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8903-8909
[6]  
HAMBERG M, 1967, J BIOL CHEM, V242, P5336
[7]   Prostaglandin synthase 2 [J].
Herschman, HR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01) :125-140
[8]   Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis [J].
Kalgutkar, AS ;
Crews, BC ;
Marnett, LJ .
BIOCHEMISTRY, 1996, 35 (28) :9076-9082
[9]   Aspirin-like molecules that covalently inactivate cyclooxygenase-2 [J].
Kalgutkar, AS ;
Crews, BC ;
Rowlinson, SW ;
Garner, C ;
Seibert, K ;
Marnett, LJ .
SCIENCE, 1998, 280 (5367) :1268-1270
[10]   Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [J].
Kurumbail, RG ;
Stevens, AM ;
Gierse, JK ;
McDonald, JJ ;
Stegeman, RA ;
Pak, JY ;
Gildehaus, D ;
Miyashiro, JM ;
Penning, TD ;
Seibert, K ;
Isakson, PC ;
Stallings, WC .
NATURE, 1996, 384 (6610) :644-648